Mingkuan Lyu

Mingkuan Lyu

Auto-generated profile, based on publicly available information

Mingkuan Lyu

Department of Chemistry The University of Texas at Austin Austin TX 78712 USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
YMYuan Ma
Yuan Ma
WGWeijie Guo
Weijie Guo
QMQuanbing Mou
Quanbing Mou
XSXiangli Shao
Xiangli Shao
MLMingkuan Lyu
Mingkuan Lyu
YLYi Lu
Yi Lu

22 June 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MLMingkuan Lyu
Mingkuan Lyu
LKLinggen Kong
Linggen Kong
ZYZhenglin Yang
Zhenglin Yang
Yuting WuYuting Wu
Yuting Wu
CMClaire E. McGhee
Claire E. McGhee
YLYi Lu
Yi Lu

3 July 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
WGWeijie Guo
Weijie Guo
SHSihao Huang
Sihao Huang
XSXiangli Shao
Xiangli Shao
YWYuting Wu
Yuting Wu
YMYuan Ma
Yuan Ma
YLYi Lu
Yi Lu
Neutrophils release neutrophil extracellular traps (NETs) to neutralize infections, a process that also contributes to immunothrombosis. While beneficial in localized infections, excessive NET formation can lead to widespread coagulopathy and organ failure. While the roles of NET-associated proteins such as histones in immunothrombosis are well characterized, NET-derived DNAs are much less known. To address this issue, we report herein the direct interaction between thrombin and DNA scaffolds and further, the identification of short tandem repeats of single-stranded (ATTCC) n in NETs that selectively bind thrombin, a crucial enzyme involved in both blood clot formation and immune response. We have also developed a strategy of selective targeting ss(ATTCC) n using antisense locked nucleic acids (LNAs), effectively disrupting NET–thrombin interactions. This finding reveals an unexplored role of single strand DNA (ssDNA) within NETs and provides a broad avenue for developing targeted therapeutic interventions for immunothrombosis-related disorders.

1 August 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
MLMingkuan Lyu
Mingkuan Lyu
LKLinggen Kong
Linggen Kong
XSXiangli Shao
Xiangli Shao
YLYi Lu
Yi Lu
Site‐directed mutagenesis (SDM) is a key driver for many biochemical investigations and biotechnological applications. Despite decades of development, it is still difficult to perform SDM on some sequences, including highly repetitive ones, because polymerase chain reaction (PCR) is often used as the most effective method for SDM, but results in complicated products with these sequences. To overcome this limitation, we report herein a PCR‐free SDM method that uses DNA‐cleaving DNAzymes. Since these DNAzymes lack the capability of cleaving double‐stranded DNA, we employed single‐stranded DNAs as assisting DNAs to open superhelical plasmids, allowing the DNA‐cleaving DNAzymes to cleave the plasmid. Such a system, named single‐stranded DNA‐assisted double‐stranded DNA nicking by DNAzymes (DANDA), expanded the substrate scope of DNAzymes to double‐stranded, superhelical plasmids. We showed that DANDA is highly customizable and target‐specific, which allows successful generation of mutations on a plasmid containing PCR‐incompatible repetitive sequences. By using solely unmodified DNA oligos that are more cost‐effective and easier to prepare than other systems that employ either PNA or restriction enzymes, this DANDA system further expands the applications of DNA‐cleaving DNAzymes in synthetic biology for different biochemical and biotechnological applications.


1 August 2025 in Angewandte Chemie
Verified
Journal Article
Open access
MLMingkuan Lyu
Mingkuan Lyu
LKLinggen Kong
Linggen Kong
XSXiangli Shao
Xiangli Shao
YLYi Lu
Yi Lu
Site‐directed mutagenesis (SDM) is a key driver for many biochemical investigations and biotechnological applications. Despite decades of development, it is still difficult to perform SDM on some sequences, including highly repetitive ones, because polymerase chain reaction (PCR) is often used as the most effective method for SDM, but results in complicated products with these sequences. To overcome this limitation, we report herein a PCR‐free SDM method that uses DNA‐cleaving DNAzymes. Since these DNAzymes lack the capability of cleaving double‐stranded DNA, we employed single‐stranded DNAs as assisting DNAs to open superhelical plasmids, allowing the DNA‐cleaving DNAzymes to cleave the plasmid. Such a system, named single‐stranded DNA‐assisted double‐stranded DNA nicking by DNAzymes (DANDA), expanded the substrate scope of DNAzymes to double‐stranded, superhelical plasmids. We showed that DANDA is highly customizable and target‐specific, which allows successful generation of mutations on a plasmid containing PCR‐incompatible repetitive sequences. By using solely unmodified DNA oligos that are more cost‐effective and easier to prepare than other systems that employ either PNA or restriction enzymes, this DANDA system further expands the applications of DNA‐cleaving DNAzymes in synthetic biology for different biochemical and biotechnological applications.